Pathogenesis of primary chronic venous disease:: Insights from animal models of venous hypertension

被引:107
作者
Bergan, John J. [1 ]
Pascarella, Luigi [2 ]
Schmid-Schonbein, Geert W. [2 ]
机构
[1] Univ Calif San Diego, Dept Surg, La Jolla, CA 92037 USA
[2] Univ Calif San Diego, Whitaker Inst Biomed Engn, Dept Bioengn, La Jolla, CA 92093 USA
关键词
D O I
10.1016/j.jvs.2007.09.028
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Reflux of blood through incompetent venous valves is a major cause of the venous hypertension that underlies clinical manifestations of chronic venous disease, including varicose veins, lipodermatosclerosis, and venous ulcers. Objective: To review published literature relating to animal models in which venous hypertension has been produced and which have yielded information on the mechanisms by which venous hypertension may trigger inflammation and cause changes in the skin and venous valves. Methods. Medline searches, with additional papers identified from reference lists in published papers. Results: At least three types of animal model were identified that have contributed to a better understanding of the trigger mechanisms and role of inflammatory processes in chronic venous disease. These models involve venous hypertension induced either by acute venular occlusion, placement of a chronic arteriovenous fistula, or ligation of several large veins. Model results suggest that elevated venous pressure and altered flow can trigger inflammatory cascades in the vein wall and venous valves which can cause progressive valvular incompetence and eventual valvular destruction, and which are also important in the skin changes associated with venous disease. Treatment with agents that reduce oxidative stress by scavenging free radicals and that inhibit the inflammatory cascade can prevent the progressive deterioration of function in valves exposed to elevated venous pressure and can prevent the development of reflux blood flow. Conclusions. Understanding these processes suggests potential therapeutic targets that could be effective in slowing or preventing progression, and could help promote a more positive and proactive attitude towards treatment of the underlying disease process, rather than the later manifestations of chronic venous disease.
引用
收藏
页码:183 / 192
页数:10
相关论文
共 85 条
[1]   CHELATING AND FREE-RADICAL SCAVENGING MECHANISMS OF INHIBITORY-ACTION OF RUTIN AND QUERCETIN IN LIPID-PEROXIDATION [J].
AFANASEV, IB ;
DOROZHKO, AI ;
BRODSKII, AV ;
KOSTYUK, VA ;
POTAPOVITCH, AI .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (11) :1763-1769
[2]   LEUKOCYTE-ENDOTHELIAL CELL-ADHESION IN SPONTANEOUSLY HYPERTENSIVE AND NORMOTENSIVE RATS [J].
ARNDT, H ;
SMITH, CW ;
GRANGER, DN .
HYPERTENSION, 1993, 21 (05) :667-673
[3]   Leg intramuscular pressures during locomotion in humans [J].
Ballard, RE ;
Watenpaugh, DE ;
Breit, GA ;
Murthy, G ;
Holley, DC ;
Hargens, AR .
JOURNAL OF APPLIED PHYSIOLOGY, 1998, 84 (06) :1976-1981
[4]   Mechanisms of disease:: Chronic venous disease [J].
Bergan, John J. ;
Schmid-Schoenbein, Geert W. ;
Smith, Philip D. Coleridge ;
Nicolaides, Andrew N. ;
Boisseau, Michel R. ;
Eklof, Bo .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (05) :488-498
[5]  
Bergqvist J, 2001, AM J ENOL VITICULT, V52, P1
[6]   Effects of oral administration of purified micronized flavonoid fraction on increased microvascular permeability induced by various agents and on ischemia/reperfusion in the hamster cheek pouch [J].
Bouskela, E ;
Donyo, KA .
ANGIOLOGY, 1997, 48 (05) :391-399
[7]  
BUDD TW, 1990, J MED, V21, P181
[8]  
Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO
[9]  
2-6
[10]  
CARTER WO, 1994, J LEUKOCYTE BIOL, V55, P253